1 / 4

Candidiasis Global Clinical Trials Review, H1, 2017 - Radiant Insights

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

RadiantInsightsri
Download Presentation

Candidiasis Global Clinical Trials Review, H1, 2017 - Radiant Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Candidiasis Global Clinical Trials Review, H1, 2017 - Radiant Insights, Inc “The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.” Radiant Insights clinical trial report, "Candidiasis Global Clinical Trials Review, H1, 2017" provides an overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Candidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in- progress trials (based on number of ongoing trials). Radiant Insights Clinical Trial Reports are generated using Radiant Insights proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Browse Full Research Report: http://www.radiantinsights.com/research/candidiasis-global-clinical-trials- review-h1-2017 Follow Us:

  2. Scope •The report provides a snapshot of the global clinical trials landscape •Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status •The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company •The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment •The Report provides enrollment trends for the past five years •Report provides latest news for the past three months Request A Sample Copy Of This Report: http://www.radiantinsights.com/research/candidiasis-global-clinical-trials- review-h1-2017/request-sample Reasons To Buy •Assists in formulating key business strategies with regards to investment •Helps in identifying prominent locations for conducting clinical trials which saves time and cost •Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities •Supports understanding of trials count and enrollment trends by country in global therapeutics market •Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials •Facilitates clinical trial assessment of the indication on a global, regional and country level Table of Contents: •Table of Contents 2 •List of Tables 4 •List of Figures 5 Follow Us:

  3. •Report Guidance 6 •Radiant Insights Clinical Trials Report Coverage 7 •Clinical Trials by Region 8 •Clinical Trials and Average Enrollment by Country 9 •Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 •Top Five Countries Contributing to Clinical Trials in Europe 12 •Top Countries Contributing to Clinical Trials in North America 13 •Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14 •Top Five Countries Contributing to Clinical Trials in Central and South America 15 •Clinical Trials by G7 Countries: Proportion of Candidiasis to Infectious Disease Clinical Trials 16 •Clinical Trials by Phase in G7 Countries 17 •Clinical Trials in G7 Countries by Trial Status 18 •Clinical Trials by E7 Countries: Proportion of Candidiasis to Infectious Disease Clinical Trials 19 •Clinical Trials by Phase in E7 Countries 20 •Clinical Trials in E7 Countries by Trial Status 21 •Clinical Trials by Phase 22 •In Progress Trials by Phase 23 •Clinical Trials by Trial Status 24 •Clinical Trials by End Point Status 25 •Subjects Recruited Over a Period of Time 26 •Clinical Trials by Sponsor Type 27 •Prominent Sponsors 28 •Top Companies Participating in Candidiasis Therapeutics Clinical Trials 29 •Prominent Drugs 30 •Latest Clinical Trials News on Candidiasis 31 •May 30, 2017: Cidara Therapeutics Announces Presentations at ASM Microbe 2017 and the 22nd Congress of the European Hematology Association 31 •May 24, 2017: Eight SCY-078 Data Presentations at ASM Microbe 2017 Confirm Potential of SCYNEXIS' Lead Agent to Combat Serious and Life-threatening Fungal Infections 31 •May 11, 2017: Potent in vitro Activity of SCYNEXIS SCY-078 Against Multidrug- Resistant Fungal Pathogen Candida auris Further Confirmed in an in vitro Study Conducted by the Centers for Disease Control and Prevention 32 •May 08, 2017: SCYNEXIS Provides Update on IV Formulation Development Status 33 •Apr 25, 2017: Eight Data Presentations at ECCMID Showcase the Broad Applicability of SCYNEXIS' Lead Anti-infective Candidate SCY-078 33 See More Reports of This Category by Radiant Insights: http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare Follow Us:

  4. About Radiant Insights, Inc: Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Grand View Research, Inc.201 Spear St #1100, Suite #3036San Francisco, CA 94105 Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Web: http://www.radiantinsights.com/ Follow Us:

More Related